Header Logo

Connection

Sheila Weinmann to Breast Neoplasms

This is a "connection" page, showing publications Sheila Weinmann has written about Breast Neoplasms.
Connection Strength

1.752
  1. Cellular senescence predicts breast cancer risk from benign breast disease biopsy images. Breast Cancer Res. 2025 Mar 11; 27(1):37.
    View in: PubMed
    Score: 0.140
  2. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr. 2005; (35):33-8.
    View in: PubMed
    Score: 0.138
  3. Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations. Am J Manag Care. 2003 Nov; 9(11):745-55.
    View in: PubMed
    Score: 0.128
  4. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort. Breast Cancer Res. 2023 05 03; 25(1):50.
    View in: PubMed
    Score: 0.123
  5. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study. Lancet Oncol. 2022 11; 23(11):1451-1464.
    View in: PubMed
    Score: 0.119
  6. A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):93-102.
    View in: PubMed
    Score: 0.118
  7. Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. JNCI Cancer Spectr. 2022 May 02; 6(3).
    View in: PubMed
    Score: 0.115
  8. Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016. Breast Cancer Res Treat. 2022 May; 193(1):203-216.
    View in: PubMed
    Score: 0.114
  9. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat Commun. 2021 11 03; 12(1):6341.
    View in: PubMed
    Score: 0.111
  10. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer. Breast Cancer Res. 2021 01 30; 23(1):15.
    View in: PubMed
    Score: 0.105
  11. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition. Mol Carcinog. 2020 07; 59(7):701-712.
    View in: PubMed
    Score: 0.099
  12. Response to Comment on "Bariatric Surgery is Associated With Reduced Risk of Breast Cancer in Both Premenopausal and Postmenopausal Women". Ann Surg. 2020 02; 271(2):e19-e20.
    View in: PubMed
    Score: 0.098
  13. RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery. BMC Med Genomics. 2019 12 19; 12(1):195.
    View in: PubMed
    Score: 0.098
  14. A miRNA Expression Signature in Breast Tumor Tissue Is Associated with Risk of Distant Metastasis. Cancer Res. 2019 04 01; 79(7):1705-1713.
    View in: PubMed
    Score: 0.092
  15. HER2 evaluation and its impact on breast cancer treatment decisions. Public Health Genomics. 2012; 15(1):1-10.
    View in: PubMed
    Score: 0.054
  16. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection? J Natl Cancer Inst Monogr. 2005; (35):39-46.
    View in: PubMed
    Score: 0.035
  17. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst. 2004 Oct 20; 96(20):1518-27.
    View in: PubMed
    Score: 0.034
  18. Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs. Genet Med. 2003 Nov-Dec; 5(6):444-50.
    View in: PubMed
    Score: 0.032

© 2025 Kaiser Permanente